Israel Englander Reata Pharmaceuticals Inc Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $27.1 Million - $36.1 Million	342,204 Added 159.86%	556,264 $56.7 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $16.9 Million - $51.2 Million	-549,212 Reduced 71.95%	214,060 $19.5 Million
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $3.13 Million - $5.95 Million	141,179 Added 22.69%	763,272 $29 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $9.12 Million - $17.1 Million	469,627 Added 308.02%	622,093 $15.6 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $1.78 Million - $3.15 Million	-86,175 Reduced 36.11%	152,466 $4.63 Million
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $8.93 Million - $14.7 Million	-370,310 Reduced 60.81%	238,641 $7.82 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $15.5 Million - $67.1 Million	604,688 Added 14184.56%	608,951 $16.1 Million
Q3 2021 Nov 15, 2021	BUY	$100.0 - $143.02 $426,300 - $609,694	4,263 New	4,263 $429,000
Q2 2021 Aug 16, 2021	SELL	$78.27 - $151.29 $4.36 Million - $8.43 Million	-55,723 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$94.25 - $132.81 $9.23 Million - $13 Million	-97,920 Reduced 63.73%	55,723 $5.56 Million
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $13.1 Million - $23.7 Million	-128,364 Reduced 45.52%	153,643 $19 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $3.38 Million - $5.91 Million	-36,170 Reduced 11.37%	282,007 $27.5 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $12.1 Million - $16.9 Million	95,871 Added 43.13%	318,177 $49.6 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $1.07 Million - $2.14 Million	8,623 Added 4.04%	222,306 $32.1 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.57 Million - $4.6 Million	21,108 Added 10.96%	213,683 $43.7 Million
Q3 2019 Nov 14, 2019	SELL	$71.26 - $95.75 $16.4 Million - $22 Million	-230,286 Reduced 54.46%	192,575 $15.5 Million
Q2 2019 Aug 15, 2019	BUY	$77.72 - $94.35 $10.3 Million - $12.4 Million	131,952 Added 45.36%	422,861 $39.9 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $15.4 Million - $18.7 Million	-198,016 Reduced 40.5%	290,909 $7.68 Million
Q1 2019 May 14, 2019	BUY	$51.9 - $101.79 $18.3 Million - $36 Million	353,267 Added 260.41%	488,925 $41.8 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $76.44 $1.76 Million - $2.76 Million	36,116 Added 36.28%	135,658 $7.61 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $3.23 Million - $8.36 Million	90,761 Added 1033.61%	99,542 $8.14 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $175,093 - $359,669	8,781 New	8,781 $307,000
Q4 2017 Feb 14, 2018	SELL	$22.39 - $33.27 $831,721 - $1.24 Million	-37,147 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $976,594 - $1.18 Million	37,147	37,147 $1.16 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account